微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.29% | 209.46% | -8.4% | 33/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.5% | 207.14% | -3.47% | 72/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.59% | 33.51% | 110.57% | 75/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.23% | 41.38% | 66.22% | 78/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.74% | 100% | 131.71% | 79/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -2.33% | -206.07% | -220.28% | 107/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.94% | -57.73% | 122.99% | 88/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.87% | -65.2% | 135.14% | 88/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.37% | -86.19% | -83.18% | 94/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.2% | 322.9% | -52.07% | 93/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.59% | -33.19% | 83.6% | 68/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.5% | -44.44% | -6.72% | 71/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.68% | 0% | 371.53% | 47/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | -0.99% | -133% | -114.37% | 114/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.87% | -10.89% | 52.67% | 72/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.5% | 16.88% | 67.91% | 72/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.68% | 31.37% | -10.4% | 60/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 2.99% | 148.88% | -61.2% | 113/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.71% | 12.88% | 100.26% | 75/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.85% | 3.77% | 88.73% | 93/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.04% | 12.71% | 133.33% | 72/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -6.12% | -156.93% | -189.6% | 120/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 6.83% | -24.7% | 84.1% | 63/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.71% | -35.92% | 104.97% | 81/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.81% | -36.71% | -83.16% | 45/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 10.75% | 66.93% | 18.52% | 74/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.07% | 20.93% | 56.65% | 35/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.79% | 26.7% | 102.45% | 37/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.86% | 20.17% | -55.59% | 20/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 6.44% | -31.71% | -14.13% | 83/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 7.5% | -4.82% | 64.11% | 33/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.57% | -6.54% | 92.02% | 31/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.38% | 15.53% | -74.76% | 26/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.43% | -1.87% | 19.67% | 66/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.88% | 13.38% | 61.15% | 28/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.89% | 6.07% | 137.38% | 34/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.06% | -3.29% | -78.56% | 25/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 9.61% | 18.06% | 38.27% | 53/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.95% | 18.8% | 50.76% | 21/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.61% | 16.12% | 116.43% | 28/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.13% | 5.97% | -73.83% | 17/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |